Mechanisms of vasoinhibitory effect of cardioprotective agent, CP-060S, in rat aorta

European Journal of Pharmacology

Volumn 400, Issue 2-3, 2000, Pages 225-230

  Sato, Koichi ^a   Satake, Nobuhiro ^b   Shibata, Shoji ^b   Adachi, Yuichiro ^c   Karaki, Hideaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF HAWAII   (United States)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Aorta; Ca2+; Ca2+ channel; CP 060S; Cytosolic; L type voltage dependent; rat

Indexed keywords

2 (3,5 DI TERT BUTYL 4 HYDROXYPHENYL) 3 [3 [N METHYL N [2 (3,4 METHYLENEDIOXYPHENOXY)ETHYL]AMINO]PROPYL] 4 THIAZOLIDINONE; ANGIOTENSIN; CALCIUM; CALCIUM CHANNEL; COPPER ION; NIFEDIPINE; PHENYLEPHRINE; PROSTAGLANDIN F2 ALPHA; VASOPRESSIN;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HEART PROTECTION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ANGIOTENSIN II; ANIMALS; ANTI-ARRHYTHMIA AGENTS; AORTA, THORACIC; ARGININE VASOPRESSIN; CALCIUM; CALCIUM CHANNEL BLOCKERS; CYTOSOL; DINOPROST; DRUG INTERACTIONS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; PHENYLEPHRINE; RATS; RATS, WISTAR; THIAZOLES; THIAZOLIDINES; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0034698339     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00358-7     Document Type: Article

References (19)

1. Adachi Y., Suzuki Y., Homma N., Fukazawa M., Tamura K., Nishie I., Kuromaru O. The anti-ischemic effects of CP-060S during pacing-induced ischemia in anesthetized dogs. Eur. J. Pharmacol. 367:1999;267-273.
2. Fukuzawa M., Tanabe S., Tamura K., Adachi Y., Fukazawa M., Kato T. Electrophysiological studies of CP-060S, a novel cardioprotective agent, in papillary muscles and cardiomyocytes. Jpn. J. Pharmacol. 73:1997;A461.
3. Karaki H., Ozaki H., Hori H., Mitsui-Saito M., Harada K., Miyamoto S., Nakazawa H., Won K.J., Sato K. Calcium movements, distribution, and functions in smooth muscle. Phamacol. Rev. 49(2):1997;157-230.
4. Karaki H., Sato K., Ozaki H. Different effects of norepinephrine and KCl on the cytosolic Ca-tension relationship in vascular muscle of rat aorta. Eur. J. Pharmacol. 151:1988;325-328.
5. Karaki H., Sato K., Ozaki H. Different effect of verapamil on cytosolic Ca and contraction in norepinephrine-stimulated vascular smooth muscle. Jpn. J. Pharmacol. 55:1991;35-42.
6. 2+ sensitization of smooth muscle contraction through myosin light chain phosphorylation. J. Biol. Chem. 266(3):1991;1708-1715.
7. Koga T., Akima M., Tamura K., Suzuki Y., Kato T., Nabata H. The inhibitory effects of CP-060S on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. Jpn. J. Pharmacol. 71:1996;A321.
8. Kuriyama H., Kitamura K., Nabata H. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol. Rev. 47(3):1995;387-573.
9. 2+ sensitivity in alpha-toxin permeabilized arterial smooth muscle. Biochem. Biophys. Res. Commun. 157(2):1988;677-683.
10. Ohya Y., Adachi M., Setoguchi M., Abe I., Fujishima M. Effects of CP-060S on membrane channels in vascular smooth muscle cells from guinea pig. Eur. J. Pharmacol. 330:1997;93-99.
11. Ozaki H., Sato K., Satoh T., Karaki H. Simultaneous recordings of calcium signals and mechanical activity using fluorescent dye fura 2 in isolated strips of vascular smooth muscle. Jpn. J. Pharmacol. 45:1987;429-433.
12. Sato K., Ozaki H., Karaki H. Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura 2. J. Pharmacol. Exp. Ther. 246:1988;294-300.
13. 2+ antagonists. Yamada K., Shibata S. Recent Advances in Calcium Channels and Calcium Antagonists. 1990;77 Pergamon, New York.
14. Shibata S., Wakabayashi S., Satake N., Hester R.K., Veda S., Tomiyama A. Mode of vasorelaxing action of 5-[3[[2-(3,4 dimethoxyphenyl)-ethyl]amino]-1-oxopropyl]-2,3,4,5-tetrahydro-1,5- benzothiazepine fumarate (KT-362), a new intracellular calcium antagonist. J. Pharmacol. Exp. Ther. 240:1987;16-22.
15. Suzuki Y., Tamura K., Akima M., Adachi Y., Tukazawa M., Kato T. CP-060S, a novel cardioprotective drug, limits myocardial infarct size in anesthetized dogs. J. Cardiovasc. Pharmacol. 31:1998a;400-407.
16. 2+ channel. Eur. J. Pharmacol. 342:1998b;347-351.
17. 2+ overload in cardiomyocytes and mechanical activities in vascular strips. Eur. J. Pharmacol. 312:1996;195-202.
18. Tanabe S., Fukazawa M., Tamura K., Kimura J., Kuromaru O. Electrophysiological effects of CP-060S, a novel cardioprotective agent, in guinea pig papillary muscles and cardiomyocytes. FASEB J. 11:1997;A499.
19. Vorndran C., Minta A., Poenie M. New fluorescent calcium indicators designed for cytosolic retension or measuring calcium near membranes. Biophys. J. 69:1995;2112-2114.